NEW YORK (360Dx) – A quantitative interferon-gamma release assay can identify young children with latent tuberculosis who are at risk of developing active cases of the disease, according to a new study.

The researchers added that their findings could lead to changes in international guidelines, which currently do not recommend the use of such tests in children.